Kontafarma China Holdings Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Chaowen Jiang
Chief Executive Officer (CEO)
HK$2.8m
Compensación total
| Porcentaje del salario del CEO | 60.9% |
| Permanencia del CEO | 6.4yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 3.7yrs |
| Promedio de permanencia en la Junta Directiva | 8.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Health Check: How Prudently Does Kontafarma China Holdings (HKG:1312) Use Debt?
Dec 28
Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?
Sep 01Is Kontafarma China Holdings (HKG:1312) Using Debt Sensibly?
Dec 29Health Check: How Prudently Does Tongfang Kontafarma Holdings (HKG:1312) Use Debt?
Sep 15Tongfang Kontafarma Holdings (HKG:1312) Has Debt But No Earnings; Should You Worry?
Apr 20Is Tongfang Kontafarma Holdings (HKG:1312) A Risky Investment?
Nov 04Tongfang Kontafarma Holdings' (HKG:1312) Shareholders Are Down 90% On Their Shares
Feb 18These 4 Measures Indicate That Tongfang Kontafarma Holdings (HKG:1312) Is Using Debt Extensively
Dec 07Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -HK$29m |
| Sep 30 2023 | n/a | n/a | -HK$12m |
| Jun 30 2023 | n/a | n/a | HK$5m |
| Mar 31 2023 | n/a | n/a | -HK$40m |
| Dec 31 2022 | HK$3m | HK$2m | -HK$85m |
| Sep 30 2022 | n/a | n/a | -HK$24m |
| Jun 30 2022 | n/a | n/a | -HK$10m |
| Mar 31 2022 | n/a | n/a | -HK$29m |
| Dec 31 2021 | HK$3m | HK$1m | -HK$48m |
| Jun 30 2021 | n/a | n/a | -HK$119m |
| Mar 31 2021 | n/a | n/a | -HK$81m |
| Dec 31 2020 | HK$2m | HK$2m | -HK$42m |
| Jun 30 2020 | n/a | n/a | HK$66m |
| Mar 31 2020 | n/a | n/a | HK$60m |
| Dec 31 2019 | HK$2m | HK$2m | HK$54m |
| Sep 30 2019 | n/a | n/a | HK$29m |
| Jun 30 2019 | n/a | n/a | HK$22m |
| Mar 31 2019 | n/a | n/a | HK$27m |
| Dec 31 2018 | HK$2m | HK$2m | HK$32m |
| Sep 30 2018 | n/a | n/a | HK$12m |
| Jun 30 2018 | n/a | n/a | -HK$8m |
| Mar 31 2018 | n/a | n/a | -HK$5m |
| Dec 31 2017 | HK$1m | HK$57k | -HK$2m |
Compensación vs. Mercado: La compensación total de Chaowen($USD355.78K) está por encima de la media de empresas de tamaño similar en el mercado Hong Kong ($USD234.25K).
Compensación vs. Ingresos: La compensación de Chaowen ha aumentado mientras la empresa no es rentable.
CEO
Chaowen Jiang (58 yo)
6.4yrs
Permanencia
HK$2,788,000
Compensación
Mr. Chaowen Jiang is Chief Executive Officer of Tongfang Kontafarma Holdings Ltd since December 11, 2017 and its Executive Director since January 23, 2018. He has been Vice President at Kontafarma China Ho...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 2.7yrs | sin datos | sin datos | |
| VP, CEO & Executive Director | 6.4yrs | HK$2.79m | sin datos | |
| Executive Director | 2.1yrs | sin datos | sin datos | |
| VP, CFO & Company Secretary | 9.5yrs | sin datos | sin datos | |
| VP & COO | 3.7yrs | sin datos | sin datos |
3.7yrs
Permanencia media
51yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de 1312 se considera experimentado (3.6 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Executive Chairman | 2.7yrs | sin datos | sin datos | |
| VP, CEO & Executive Director | 6.3yrs | HK$2.79m | sin datos | |
| Executive Director | 3.7yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 12.4yrs | HK$118.00k | sin datos | |
| Independent Non-Executive Director | 9.8yrs | HK$118.00k | sin datos | |
| Non-Executive Director | 10.2yrs | HK$2.01m | sin datos | |
| Independent Non-Executive Director | 8.8yrs | HK$118.00k | sin datos |
8.8yrs
Permanencia media
53yo
Promedio de edad
Junta con experiencia: La junta directiva de 1312 se considera experimentada (8.7 años de antigüedad promedio).